Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 1/20 | 0.64 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.61 |
| ▸ | PPARG | P37231 | 7/20 | 0.61 |
| ▸ | PPARD | Q03181 | 7/20 | 0.61 |
| ▸ | PPARA | Q07869 | 7/20 | 0.61 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.61 |
| ▸ | TSHR | P16473 | 4/20 | 0.61 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | TLR2 | O60603 | 2/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.61 |
| ▸ | FABP4 | P15090 | 2/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.61 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.61 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.61 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.61 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hexanoate SCHEMBL14248555 | 0.93 | AKR1B1 (0.76) | AKR1B1GPR84PPARGPPARDPPARA | |
| Hexanoate SCHEMBL7291690 | 0.93 | AKR1B1 (0.76) | AKR1B1GPR84PPARGPPARDPPARA | |
| Dodecanoate SCHEMBL10903682 | 0.91 | GPR84 (0.77) | AKR1B1GPR84PPARGPPARDPPARA | |
| Decanoic Acid SCHEMBL28071615 | 0.91 | GPR84 (0.77) | AKR1B1GPR84PPARGPPARDPPARA | |
| Octanoic Acid SCHEMBL7716085 | 0.91 | GPR84 (0.77) | AKR1B1GPR84PPARGPPARDPPARA | |
| Octanoic Acid SCHEMBL5312548 | 0.91 | GPR84 (0.77) | AKR1B1GPR84PPARGPPARDPPARA | |
| Valeric Acid SCHEMBL7336190 | 0.88 | AKR1B1 (0.61) | AKR1B1GPR84PPARGPPARDPPARA | |
| Glutarate SCHEMBL27861477 | 0.87 | SLC22A6 (0.65) | AKR1B1GPR84PPARGPPARDPPARA | |
| Adipic Acid SCHEMBL8841100 | 0.87 | LMNA (0.65) | AKR1B1GPR84PPARGPPARDPPARA | |
| Valeric Acid SCHEMBL1331662 | 0.87 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2844691-B1 | PLASTICISER COMPOSITIONS COMPRISING GELIFICATION ACCELERATORS BASED ON ESTER(S) OF 1,4 : 3,6-DIANHYDROHEXITOL HAVING LOW MOLAR WEIGHT | ROQUETTE FRERES (FR) | 2019-08-14 | — | — | EP | claimed |
| EP-2844691-A2 | PLASTICISER COMPOSITIONS COMPRISING GELIFICATION ACCELERATORS BASED ON ESTER(S) OF 1,4 : 3,6-DIANHYDROHEXITOL HAVING LOW MOLAR WEIGHT | Roquette Frères (FR) | 2015-03-11 | — | — | EP | claimed |
| WO-2013164545-A2 | PLASTICISER COMPOSITIONS COMPRISING GELIFICATION ACCELERATORS BASED ON ESTER(S) OF 1,4 : 3,6-DIANHYDROHEXITOL HAVING LOW MOLAR WEIGHT | ROQUETTE FRERES (FR) | 2013-11-07 | — | — | WO | claimed |
| US-3981831-A | REACTION OF ORGANIC POLYISOCYANATE WITH ALKALI METAL SILICATE OR SILICA SOL | BAYER AKTIENGESELLSCHAFT (DT) | 1976-09-21 | — | — | US | claimed |
| US-20230124503-A1 | GINSENOSIDE COMPOSITIONS | GIVAUDAN SA (CH) | 2023-04-20 | — | — | US | disclosed |
| US-20220229077-A1 | DIAGNOSIS, PROGNOSIS AND TREATMENT FOR SCHIZOPHRENIA AND SCHIZOAFFECTIVE PSYCHOSIS | PRECISION MEDICINE HOLDINGS PTY LTD (AU) | 2022-07-21 | — | — | US | disclosed |
| CN-110023752-B | Diagnosis, prognosis and treatment of schizophrenia and schizoaffective disorders | 精密医药控股私人有限公司 | 2021-06-29 | — | — | CN | disclosed |
| US-20200049722-A1 | DIAGNOSIS, PROGNOSIS AND TREATMENT FOR SCHIZOPHRENIA AND SCHIZOAFFECTIVE PSYCHOSIS | PRECISION MEDICINE HOLDINGS PTY LTD (AU) | 2020-02-13 | — | — | US | disclosed |
| EP-2844691-B1 | PLASTICISER COMPOSITIONS COMPRISING GELIFICATION ACCELERATORS BASED ON ESTER(S) OF 1,4 : 3,6-DIANHYDROHEXITOL HAVING LOW MOLAR WEIGHT | ROQUETTE FRERES (FR) | 2019-08-14 | — | — | EP | disclosed |
| EP-3516389-A1 | DIAGNOSIS, PROGNOSIS AND TREATMENT FOR SCHIZOPHRENIA AND SCHIZOAFFECTIVE PSYCHOSIS | Precision Medicine Holdings Pty Ltd (AU) | 2019-07-31 | — | — | EP | disclosed |
| EP-3087392-B1 | MENTAL ILLNESS MODEL AND MENTAL ILLNESS RISK ASSESSMENT TEST FOR SCHIZOPHRENIC PSYCHOSIS | WILLIAMS STEPHANIE SUE (AU) | 2018-10-31 | — | — | EP | disclosed |
| WO-2018053605-A1 | DIAGNOSIS, PROGNOSIS AND TREATMENT FOR SCHIZOPHRENIA AND SCHIZOAFFECTIVE PSYCHOSIS | PRECISION MEDICINE HOLDINGS PTY LTD (AU) | 2018-03-29 | — | — | WO | disclosed |
| WO-2013164545-A2 | PLASTICISER COMPOSITIONS COMPRISING GELIFICATION ACCELERATORS BASED ON ESTER(S) OF 1,4 : 3,6-DIANHYDROHEXITOL HAVING LOW MOLAR WEIGHT | ROQUETTE FRERES (FR) | 2013-11-07 | — | — | WO | disclosed |
| US-20120094315-A1 | BIOMARKERS FOR THE DIAGNOSIS AND/OR PREDICTION OF SUSCEPTIBILITY TO MENTAL AND NEURODEGENERATIVE DISORDERS | FRYAR-WILLIAMS STEPHANIE (AU) | 2012-04-19 | — | — | US | disclosed |
| EP-2373999-A1 | NOVEL BIOMARKERS | Fryar-Williams, Stephanie (AU) | 2011-10-12 | — | — | EP | disclosed |
| WO-2010066000-A1 | NOVEL BIOMARKERS | FRYAR-WILLIAMS STEPHANIE (AU) | 2010-06-17 | — | — | WO | disclosed |
| CN-1255105-A | Cerium oxide, zirconium oxide, Ce/Zr mixed oxide and Ce/Zr solid solution with improved thermal stability and oxygen storage capacity | RHODIA (US) | 2000-05-31 | — | — | CN | disclosed |
| EP-0241147-B1 | PROCESS FOR THE PRODUCTION OF MACROLIDE COMPOUNDS | AMERICAN CYANAMID COMPANY (US) | 1990-09-26 | — | — | EP | disclosed |
| US-4567292-A | CATALYTIC VAPOR PHASE, PROPYLENE, OXYGEN, ACID | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1986-01-28 | — | — | US | disclosed |
| US-4124707-A | 7α-Halogeno-3,20-dioxo-1,4-pregnadienes, methods for their manufacture, their use as anti-inflammatory agents, and pharmaceutical formulations useful therefor | SCHERING CORPORATION (US) | 1978-11-07 | — | — | US | disclosed |